Midita Tablet 50 mg contains Lasmiditan Hemisuccinate, a novel antimigraine medication specifically developed for the acute treatment of migraine attacks with or without aura in adults. Lasmiditan belongs to a newer class of drugs known as selective serotonin (5-HT1F) receptor agonists. Unlike traditional migraine treatments such as triptans, Lasmiditan does not cause vasoconstriction, making Midita Tablet a suitable option for patients who are unable to use vasoconstrictive therapies due to cardiovascular risk factors, under physician guidance.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Lasmiditan Hemisuccinate 50 mg

• Per tablet

Therapeutic Class

• Antimigraine agent (Selective 5-HT1F receptor agonist)

Mechanism of Action

Lasmiditan works by selectively activating 5-HT1F receptors located in the trigeminal pathway, which plays a key role in migraine pathophysiology. Activation of these receptors inhibits the release of pro-inflammatory neuropeptides and reduces pain signal transmission in the central nervous system. Unlike triptans, Lasmiditan does not act on blood vessels, thereby providing effective migraine relief without causing vascular constriction.

Indications

Midita Tablet 50 mg is indicated for:

• Acute treatment of migraine attacks with or without aura in adults

• Relief of moderate to severe migraine pain

• Management of migraine-associated symptoms such as nausea, photophobia, and phonophobia, as prescribed by a physician

Midita Tablet is not intended for migraine prevention and should not be used to treat other types of headaches.

Dosage and Administration

Midita Tablet should be taken orally as soon as migraine symptoms begin or as directed by a healthcare professional. The tablet should be swallowed whole with water. The dosage and frequency depend on individual patient response and tolerability. Patients are advised not to exceed the prescribed dose within a 24-hour period. Due to its central nervous system effects, patients should strictly follow medical instructions regarding use.

Benefits of Midita Tablet

• Effective relief from acute migraine pain

• Non-vasoconstrictive mechanism, suitable for patients with cardiovascular concerns

• Reduces migraine-associated sensory sensitivity

• Targeted action on migraine pain pathways

• Convenient oral tablet formulation

Precautions and Warnings

• May cause dizziness, drowsiness, or fatigue; patients should avoid driving or operating machinery for at least 8 hours after taking the tablet

• Use with caution in patients taking other central nervous system depressants

• Not recommended for use in children and adolescents

• Should be used during pregnancy and breastfeeding only if clearly prescribed by a physician

• Not intended for chronic daily use or migraine prevention

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include dizziness, sleepiness, fatigue, tingling sensations, or nausea. These effects are generally dose-related and temporary. If severe or persistent symptoms occur, patients should seek medical advice promptly.

Storage

Store Midita Tablet 50 mg in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children. Do not use after the expiry date printed on the packaging.